So finer points of Amgen..., page-2

First 2 Last

Share
Profile

Follow
oslo

5,687 Posts.

07/01/16

20:34

Post #: 16751845
Share

Originally posted by IndiJo ↑

So outside of why are not filthy rish and retired yet or broke trading discussions....a few finer points I don't think have been really discussed.

" These terms and conditions are non-binding and, accordingly, the closing of a Potential Transaction with the Counterparty is subject to, among other things, satisfactory completion of diligence by and negotiations with the Counterparty, the execution of definitive documents, and other conditions necessary to complete the transaction, including any required regulatory approvals"

LOL, all the ifs and buts seem std issue but the fact that UNS released it, Amgen are happy to have released it then if the deal doesn't get done then UNS folk should be shot. Compromises will need to be made and expect them to be made....but the specific mention of regulatory approvals?

Would I be right in assuming this is financial/business regulatory requirements and NOT pharma regulatory approvals?

Scondly...
"In addition to the Agreement, we have a pre-existing Master Feasibility and Customization Agreement with the Counterparty entered into in the ordinary course of our business on December 2, 2015"

How is it that as an ASX listed company UNS did not release a vanilla statement on the ASX stating a multi-national pharma had signed a Feasability and Customisation agreement? It surely is associated with some sort of revenue which given the quarterly losses make it material. Its going to utilise the finite resources and include the need for further customisation/R&D which the company said was winding down. I just don't get how UNS can just roll along keeping such onfo to themselves and not releasing it on the ASX????

Expand

Stop asking so many questions you will upset the traders oops I mean new long term holders.

UNS Price at posting: 19.5¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Microcap Wrap: 5 explorers with news out today

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

RCE

Recce's R327 found effective against E.coli during clinical trial

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

There are more pages in this discussion • 23 more messages in this thread...

First 2 Last

Add UNS (ASX) to my watchlist

So finer points of Amgen..., page-2

Top Stories

Microcap Wrap: 5 explorers with news out today

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Ava Risk Group expands US presence with A$0.7M Substation Deal

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Recce's R327 found effective against E.coli during clinical trial

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Featured News